DAPAGLIFLOZIN

DAPAGLIFLOZIN: Dapagliflozin is a medication used to treat type 2 diabetes. It belongs to a class of drugs called sodium-glucose co-transporter 2 (SGLT2) inhibitors. The primary objective of dapagliflozin is to lower blood sugar levels.

The mechanism of action of dapagliflozin involves inhibiting the SGLT2 protein in the kidneys. This protein is responsible for reabsorbing glucose back into the bloodstream. By inhibiting SGLT2, dapagliflozin reduces glucose reabsorption, allowing excess glucose to be excreted through urine. This leads to a decrease in blood sugar levels.

The usual dose of dapagliflozin is 5 mg once daily, taken orally. This can be increased to 10 mg once daily in some patients who may need additional glucose-lowering effect. It is important to follow the dosage instructions provided by your healthcare professional.

Like any medication, dapagliflozin can cause side effects. Common side effects may include urinary tract infections, increased thirst, increased urination, and genital yeast infections. In rare cases, dapagliflozin may also cause low blood sugar (hypoglycemia), dehydration, kidney problems, or yeast infections in other parts of the body such as the mouth or throat.

It is crucial to consult a healthcare professional before starting dapagliflozin or any other medication and discuss the potential risks and benefits based on your specific medical condition. They will be able to provide personalized guidance on its use and monitor your response to the drug closely.